Table 7.
Sample | Conc. (ug/mL) | Mean Absorbance ± SD | Hemolysis Inhibition % | |
---|---|---|---|---|
Hypotonic Solution | Isotonic Solution | |||
Control | 1.326 ± 0.1 | 0.001 ± 0.01 | ||
ZnO NPs | 1000 | 0.158 ± 0.004 b | 0.095 ± 0.00 | 95.6 |
800 | 0.189 ± 0.003 c | 0.071 ± 0.00 | 91.8 | |
600 | 0.264 ± 0.006 d | 0.061 ± 0.00 | 85.9 | |
400 | 0.381 ± 0.005 f | 0.054 ± 0.00 | 77.3 | |
200 | 0.475 ± 0.002 h | 0.035 ± 0.00 | 69.5 | |
100 | 0.583 ± 0.012 j | 0.020 ± 0.00 | 61.0 | |
ALE | 1000 | 0.198 ± 0.007 c | 0.081 ± 0.00 | 91.9 |
800 | 0.329 ± 0.006 e | 0.065 ± 0.00 | 81.7 | |
600 | 0.426 ± 0.005 g | 0.035 ± 0.00 | 72.9 | |
400 | 0.474 ± 0.007 h | 0.031 ± 0.00 | 69.3 | |
200 | 0.544 ± 0.005 i | 0.027 ± 0.00 | 64.1 | |
100 | 0.660 ± 0.003 k | 0.022 ± 0.00 | 55.7 | |
Indomethacin | 1000 | 0.059 ± 0.002 a | 0.035 ± 0.01 | 98.1 |
Values are expressed as the mean of triplicates ± SD. Different superscripted small letters significantly differ based on LSD as a post hoc test at p ≤ 0.05.